Dr. Tamna Wangjam, M.D.

Claim this profile

LSU Health Sciences Center at Shreveport

Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
3 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
LSU Health Sciences Center At Shreveport
Image of trial facility.
Louisiana State University Health Science Center At Shreveport

Clinical Trials Tamna Wangjam, M.D. is currently running

Image of trial facility.

Lenalidomide +/- Daratumumab

for Multiple Myeloma

Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first randomization). Patients are randomized between Lenalidomide for 2 years and Lenalidomide + Daratumumab/rHuPH20. After 2 years of Maintenance, MRD is assessed to guide further therapy. MRD-positive patients will continue with the assigned treatment. MRD-negative patients will be further randomized (Reg Step 3) to either continue or discontinue the assigned treatment. Patients are treated for up to 7 years from Step 2 reg and followed for up to 15 years.
Recruiting2 awards Phase 317 criteria

More about Tamna Wangjam, M.D.

Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Tamna Wangjam, M.D. has experience with
  • Descartes-25
  • Ibrutinib
  • Autologous Hematopoietic Stem Cell Transplantation
  • Autologous Bone Marrow Transplantation
  • Lenalidomide
  • Daratumumab/rHuPH20
Breakdown of trials Tamna Wangjam, M.D. has run
Multiple Myeloma
Plasma Cell Neoplasms
Recurrence
Lymphoma
B-Cell Lymphoma

Other Doctors you might be interested in

John PangLSU Health Sciences Center at Shreveport
Kavitha BeedupalliOchsner LSU Health Monroe Medical Center
Gary V. BurtonLSU Health Sciences Center at Shreveport

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tamna Wangjam, M.D. specialize in?
Tamna Wangjam, M.D. focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Tamna Wangjam, M.D. currently recruiting for clinical trials?
Yes, Tamna Wangjam, M.D. is currently recruiting for 1 clinical trial in Shreveport Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Tamna Wangjam, M.D. has studied deeply?
Yes, Tamna Wangjam, M.D. has studied treatments such as Descartes-25, Ibrutinib, Autologous Hematopoietic Stem Cell Transplantation.
What is the best way to schedule an appointment with Tamna Wangjam, M.D.?
Apply for one of the trials that Tamna Wangjam, M.D. is conducting.
What is the office address of Tamna Wangjam, M.D.?
The office of Tamna Wangjam, M.D. is located at: LSU Health Sciences Center at Shreveport, Shreveport, Louisiana 71103 United States. This is the address for their practice at the LSU Health Sciences Center at Shreveport.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top